河北医学2018，Vol.24Issue(3)：393-396,4.DOI:10.3969/j.issn.1006-6233.2018.03.011
阿托伐他汀联合倍他乐克对冠心病合并短暂性脑缺血患者血清Hcy hs-CRP及血脂水平的影响
Effect of Atorvastatin and Betaloc on Serum Hcy hs-CRP and Serum Lipids in Patients with Coronary Heart Disease Combined with Transient Ischemia
摘要
Abstract
Objective:To investigate the effects of atorvastatin and betaloc on serum Hcy,hs-CRP and blood lipid levels in patients with coronary heart disease complicated with transient ischemic attack. Methods:80 patients with coronary heart disease complicated with transient ischemic attack admitted to our hospital from June 2015 to June 2017 were randomly divided into two groups,the control group received betaloc and the ex-perimental group received atorvastatin. The electrocardiogram (ECG) improvement, the overall treatment effect of transient ischemic attack, disease-related parameters and adverse reactions were compared between the two groups.Results:The total effective rate of electrocardiogram improvement and the total effective rate of transient ischemic treatment in experimental group were significantly higher than those in control group(P <0. 05);the thickness of intima-media,the maximum area of plaque transection, The levels of TG, TC, LDL-C, IL-8,HCY,Hs-CRP,NT-proBNP and FBG in the two groups were significantly lower than those in the control group(P <0.01). There was no significant difference(P> 0.05). Conclusion:Atorvastatin combined with betaloc has significant effect on serum Hcy,hs-CRP and serum lipid level in patients with coronary heart disease complicated with transient ischemia.关键词
阿托伐他汀/倍他乐克/冠心病/短暂性脑缺血Key words
Atorvastatin/Betaloc/Coronary heart disease/Transient ischemia引用本文复制引用
张芙蓉,齐茗,王红娟..阿托伐他汀联合倍他乐克对冠心病合并短暂性脑缺血患者血清Hcy hs-CRP及血脂水平的影响[J].河北医学,2018,24(3):393-396,4.基金项目
陕西省卫生厅科研基金项目,(编号:2016JM4021) （编号:2016JM4021）
